tiprankstipranks
China SXT Pharmaceuticals Inc (SXTC)
NASDAQ:SXTC
US Market

China SXT Pharmaceuticals (SXTC) Income Statement

Compare
231 Followers

China SXT Pharmaceuticals Income Statement

Last quarter (Q4 2024), China SXT Pharmaceuticals's total revenue was $494.46K, a decrease of -35.23% from the same quarter last year. In Q4, China SXT Pharmaceuticals's net income was $3.30M. See China SXT Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
$ 1.93M$ 1.97M$ 2.60M$ 4.78M$ 5.16M
Gross Profit
$ 553.97K$ 426.27K$ 1.25M$ 2.84M$ 2.70M
Operating Expenses
$ 3.07M$ 6.03M$ 6.44M$ 5.04M$ 4.04M
Depreciation and Amortization
$ 203.25K$ 250.16K$ 320.01K$ 345.41K$ 331.84K
EBITDA
$ -2.35M$ -5.21M$ -5.05M$ -1.85M$ -1.01M
Operating Income
$ -2.52M$ -5.61M$ -5.19M$ -2.20M$ 4.28M
Other Income/Expenses
$ -583.32K$ -327.26K$ -218.28K$ -743.79K$ -9.05M
Pretax Income
$ -3.10M$ -5.93M$ -5.41M$ -2.94M$ -10.39M
Net Income
$ -3.10M$ -5.93M$ -5.74M$ -2.75M$ -10.29M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.57$ -22.23$ -137.92$ -95.48$ -832.08
Diluted EPS
$ -3.57$ -22.23$ -137.92$ -95.48$ -832.08
Weighted Average Shares Outstanding
867.42K 266.97K 41.59K 28.78K 12.36K
Weighted Average Shares Outstanding (Diluted)
867.42K 266.97K 41.59K 28.78K 12.36K
Currency in USD

China SXT Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis